EndoChoice Holdings Inc. (NYSE:GI) shares traded down 5.3% during trading on Friday . The company traded as low as $5.32 and last traded at $5.33, with a volume of 52,582 shares changing hands. The stock had previously closed at $5.63.

A number of research analysts have commented on the stock. Zacks Investment Research downgraded shares of EndoChoice Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, May 3rd. JPMorgan Chase & Co. assumed coverage on shares of EndoChoice Holdings in a research report on Wednesday, July 13th. They set an “overweight” rating on the stock.

The stock’s market cap is $138.64 million. The stock has a 50-day moving average price of $4.84 and a 200 day moving average price of $4.99.

EndoChoice Holdings (NYSE:GI) last announced its quarterly earnings results on Wednesday, May 4th. The company reported ($0.68) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.13. During the same quarter last year, the firm posted ($1.00) earnings per share. The firm had revenue of $18.46 million for the quarter, compared to analysts’ expectations of $18.34 million. The company’s revenue was up 10.2% on a year-over-year basis. On average, analysts forecast that EndoChoice Holdings Inc. will post ($2.01) earnings per share for the current year.

An institutional investor recently raised its position in EndoChoice Holdings stock. Bank of Montreal Can boosted its stake in shares of EndoChoice Holdings Inc. (NYSE:GI) by 25.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 566,845 shares of the company’s stock after buying an additional 115,260 shares during the period. Bank of Montreal Can owned about 2.29% of EndoChoice Holdings worth $4,733,000 as of its most recent filing with the SEC.

Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.